Varilrix Chickenpox Vaccine

Varilrix Chickenpox Vaccine is a live attenuated vaccine used to protect against chickenpox, a contagious disease caused by the varicella-zoster virus. The vaccine helps the body develop immunity by stimulating the immune system to produce protective antibodies against the virus, reducing the risk of infection or significantly lowering the severity of symptoms if exposure occurs.

Healthcare professionals commonly administer Varilrix to children, adolescents, and adults who have not previously been infected with chickenpox or vaccinated against it. Vaccination helps prevent complications associated with the infection, such as skin infections, pneumonia, and inflammation of the brain. The vaccine is typically given as a subcutaneous injection and may require two doses for optimal protection.

Varilrix is widely used in immunization programs and is recommended for individuals at risk of exposure to the virus. By providing long-lasting immunity, the vaccine plays an important role in preventing outbreaks and protecting community health.

Product Features

• Contains live attenuated varicella-zoster virus for immunization.
• Helps protect against chickenpox infection.
• Stimulates the immune system to build long-lasting immunity.
• Suitable for children, adolescents, and adults without prior immunity.
• Administered as a subcutaneous injection by healthcare professionals.
• Helps reduce the severity and complications of chickenpox.

How It Helps

• Prevents infection caused by the Varicella zoster virus.
• Reduces the severity of chickenpox symptoms if infection occurs.
• Helps protect against complications such as skin infections and pneumonia.
• Supports community immunity by reducing virus transmission.
• Provides long-term protection through immune response development.